Form 8-K - Current report:
SEC Accession No. 0001564590-19-045984
Filing Date
2019-12-16
Accepted
2019-12-13 17:52:11
Documents
12
Period of Report
2019-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20191209.htm   iXBRL 8-K 52453
  Complete submission text file 0001564590-19-045984.txt   179762

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191209.xsd EX-101.SCH 5968
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191209_lab.xml EX-101.LAB 18734
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191209_pre.xml EX-101.PRE 11175
8 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20191209_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191285485
SIC: 2834 Pharmaceutical Preparations